An Effective Synthesis of Previously Unknown 7-Aryl Substituted Paullones
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
A straightforward three-step procedure affording a wide range of novel 7-aryl substituted paullone derivatives was developed. This scaffold is structurally similar to 2-(1-indol-3-yl)acetamides-promising antitumor agents-hence, could be useful for the development of a new class of anticancer drugs.
Citing Articles
Reddy M, Satyam K, Suresh S RSC Adv. 2024; 14(50):37234-37239.
PMID: 39569112 PMC: 11577158. DOI: 10.1039/d4ra07741e.
References
1.
Kunick C, Lauenroth K, Wieking K, Xie X, Schultz C, Gussio R
. Evaluation and comparison of 3D-QSAR CoMSIA models for CDK1, CDK5, and GSK-3 inhibition by paullones. J Med Chem. 2003; 47(1):22-36.
DOI: 10.1021/jm0308904.
View
2.
Yuskaitis C, Jope R
. Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity. Cell Signal. 2008; 21(2):264-73.
PMC: 2630396.
DOI: 10.1016/j.cellsig.2008.10.014.
View
3.
Fischer P, Lane D
. Inhibitors of cyclin-dependent kinases as anti-cancer therapeutics. Curr Med Chem. 2000; 7(12):1213-45.
DOI: 10.2174/0929867003374048.
View
4.
Aksenov A, Aksenov D, Arutiunov N, Aksenov N, Aleksandrova E, Zhao Z
. Synthesis of Spiro[indole-3,5'-isoxazoles] with Anticancer Activity via a Formal [4 + 1]-Spirocyclization of Nitroalkenes to Indoles. J Org Chem. 2019; 84(11):7123-7137.
DOI: 10.1021/acs.joc.9b00808.
View
5.
Falke H, Chaikuad A, Becker A, Loaec N, Lozach O, Abu Jhaisha S
. 10-iodo-11H-indolo[3,2-c]quinoline-6-carboxylic acids are selective inhibitors of DYRK1A. J Med Chem. 2015; 58(7):3131-43.
PMC: 4506206.
DOI: 10.1021/jm501994d.
View